Frank Qin is an associate in the Goodwin’s Life Sciences group and a member of the firm’s Intellectual Property Transactions and Strategies practice. Frank represents life science companies in intellectual property-driven transactions, including license agreements, collaboration agreements, co-development agreements, sponsored research agreements, clinical trial agreements, services agreements, material transfer agreements, manufacturing agreements, supply agreements, and distribution agreements. He also advises clients throughout their corporate lifecycles on the intellectual property aspects of corporate transactions, including mergers and acquisitions, financings, asset sales, and royalty monetization deals. He joined Goodwin in 2021.
Representative Matters
Frank’s recent representative experience, among others, includes:
Areas of Practice
Professional Experience
While attending law school, Frank served as a judicial intern at the U.S. District Court for the Middle District of North Carolina, participated in UNC’s Consumer Financial Transactions Clinic, and served as an Articles Editor for the North Carolina Law Review.
Prior to law school, Frank worked at Epic Systems, an electronic health record software company based in Verona, WI, in the Technical Services role for inpatient and outpatient pharmacy applications.
Professional Activities
Frank is a member of the Boston Bar Association.
Credentials
Education
JD2021
The University of North Carolina School of Law
(with honors)
BS2012
Johns Hopkins University
Admissions
Bars
- Massachusetts
- U.S. Patent and Trademark Office (USPTO)
Publications
Author, “The Debilitating Scope of Care Coordination Under HIPAA,” 98 N.C. L. REV. 1395, 2020